Clinical Trials

NEW YORK — Clinical trials for rosacea lack diversity reflective of the U.S. census and disease rates, according to a poster presentation at the Skin of Color Update 2023 meeting.

Genentech has announced positive results from its primary analysis of an ongoing study assessing safety and efficacy of Evrysdi in babies with pre-symptomatic spinal muscular atrophy.

A Bay Area pharmaceutical firm has announced positive data from a phase 3 clinical trial evaluating Chenodal tablets to treat adults with cerebrotendinous xanthomatosis, an autosomal, recessive, progressive genetic disorder.

ASCO released a research statement outlining new recommendations regarding the appropriate assessment of ovarian toxicity in cancer clinical trials.

LAS VEGAS — Visus Therapeutics completed one clinical trial for Brimochol PF, a once-daily drop for presbyopia, earlier this year and is currently enrolling patients for a second trial, a company executive said at Vision Expo West.

Members of racial and ethnic minority groups are significantly less likely to participate in cancer clinical trials than their non-Hispanic white counterparts, study results showed.

A greater proportion of older patients and individuals from historically underrepresented groups participated in NCI-funded early-phase cancer clinical trials in 2022 compared with 2000, according to study results.

PHILADELPHIA — In order for underserved communities to successfully engage in clinical research, clear communication and multidisciplinary outreach by the medical community is necessary, according to a speaker.

OKYO Pharma has completed patient enrollment for the randomized portion of its phase 2 clinical trial of OK-101, a topical treatment for dry eye disease, the company announced in a press release.

PHILADELPHIA — To effectively address symptoms of dementia with Lewy bodies, the medical community must address obstacles such as accurate diagnosis, lack of treatment options and dearth of clinical trials, according to a presenter.